암의 치료에 사용하기 위한 마스킹된 유형 I 인터페론 (IFNα 및 IFNβ)을 포함하는 융합 단백질 조성물 및 그의 방법
마스킹된 IFN을 포함하는 융합 단백질 조성물 및 마스킹된 IFN을 제조하는 방법이 본원에 개시된다. 결과적으로, 마스킹된 IFN은 Mab 또는 그의 결합 단편에 융합되고, 치료 양식으로서 환자에게 투여되고, 암, 면역학적 장애 및 다른 질환을 치료하는 방법을 제공할 수 있다. Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | VASUTHASAWAT ALEX TRIHN KHAM STOVER DAVID MORRISON SHERIE |
description | 마스킹된 IFN을 포함하는 융합 단백질 조성물 및 마스킹된 IFN을 제조하는 방법이 본원에 개시된다. 결과적으로, 마스킹된 IFN은 Mab 또는 그의 결합 단편에 융합되고, 치료 양식으로서 환자에게 투여되고, 암, 면역학적 장애 및 다른 질환을 치료하는 방법을 제공할 수 있다.
Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240021943A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240021943A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240021943A3</originalsourceid><addsrcrecordid>eNrjZJj2ZuqUN3NnKLzZOeP14p430ycovGla82bWyrdTZ7zasUHhzZyWt1PnKLxe3vGma8nbpp2vJ8wBii14O2OqgqfCm7k73rZseNs34_XCBQoanm5-5zYqvN7QrwBibdJ8M7dF4W3_mrdTVwDNet01Bahv69upKxVed694vWHjm-UdCm8WbnjTsvH1mj1gXa-27wA55PWGla83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRiYGBkaGlibGjsbEqQIAjAt3-w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>암의 치료에 사용하기 위한 마스킹된 유형 I 인터페론 (IFNα 및 IFNβ)을 포함하는 융합 단백질 조성물 및 그의 방법</title><source>esp@cenet</source><creator>VASUTHASAWAT ALEX ; TRIHN KHAM ; STOVER DAVID ; MORRISON SHERIE</creator><creatorcontrib>VASUTHASAWAT ALEX ; TRIHN KHAM ; STOVER DAVID ; MORRISON SHERIE</creatorcontrib><description>마스킹된 IFN을 포함하는 융합 단백질 조성물 및 마스킹된 IFN을 제조하는 방법이 본원에 개시된다. 결과적으로, 마스킹된 IFN은 Mab 또는 그의 결합 단편에 융합되고, 치료 양식으로서 환자에게 투여되고, 암, 면역학적 장애 및 다른 질환을 치료하는 방법을 제공할 수 있다.
Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.</description><language>kor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240219&DB=EPODOC&CC=KR&NR=20240021943A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240219&DB=EPODOC&CC=KR&NR=20240021943A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VASUTHASAWAT ALEX</creatorcontrib><creatorcontrib>TRIHN KHAM</creatorcontrib><creatorcontrib>STOVER DAVID</creatorcontrib><creatorcontrib>MORRISON SHERIE</creatorcontrib><title>암의 치료에 사용하기 위한 마스킹된 유형 I 인터페론 (IFNα 및 IFNβ)을 포함하는 융합 단백질 조성물 및 그의 방법</title><description>마스킹된 IFN을 포함하는 융합 단백질 조성물 및 마스킹된 IFN을 제조하는 방법이 본원에 개시된다. 결과적으로, 마스킹된 IFN은 Mab 또는 그의 결합 단편에 융합되고, 치료 양식으로서 환자에게 투여되고, 암, 면역학적 장애 및 다른 질환을 치료하는 방법을 제공할 수 있다.
Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJj2ZuqUN3NnKLzZOeP14p430ycovGla82bWyrdTZ7zasUHhzZyWt1PnKLxe3vGma8nbpp2vJ8wBii14O2OqgqfCm7k73rZseNs34_XCBQoanm5-5zYqvN7QrwBibdJ8M7dF4W3_mrdTVwDNet01Bahv69upKxVed694vWHjm-UdCm8WbnjTsvH1mj1gXa-27wA55PWGla83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRiYGBkaGlibGjsbEqQIAjAt3-w</recordid><startdate>20240219</startdate><enddate>20240219</enddate><creator>VASUTHASAWAT ALEX</creator><creator>TRIHN KHAM</creator><creator>STOVER DAVID</creator><creator>MORRISON SHERIE</creator><scope>EVB</scope></search><sort><creationdate>20240219</creationdate><title>암의 치료에 사용하기 위한 마스킹된 유형 I 인터페론 (IFNα 및 IFNβ)을 포함하는 융합 단백질 조성물 및 그의 방법</title><author>VASUTHASAWAT ALEX ; TRIHN KHAM ; STOVER DAVID ; MORRISON SHERIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240021943A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VASUTHASAWAT ALEX</creatorcontrib><creatorcontrib>TRIHN KHAM</creatorcontrib><creatorcontrib>STOVER DAVID</creatorcontrib><creatorcontrib>MORRISON SHERIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VASUTHASAWAT ALEX</au><au>TRIHN KHAM</au><au>STOVER DAVID</au><au>MORRISON SHERIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>암의 치료에 사용하기 위한 마스킹된 유형 I 인터페론 (IFNα 및 IFNβ)을 포함하는 융합 단백질 조성물 및 그의 방법</title><date>2024-02-19</date><risdate>2024</risdate><abstract>마스킹된 IFN을 포함하는 융합 단백질 조성물 및 마스킹된 IFN을 제조하는 방법이 본원에 개시된다. 결과적으로, 마스킹된 IFN은 Mab 또는 그의 결합 단편에 융합되고, 치료 양식으로서 환자에게 투여되고, 암, 면역학적 장애 및 다른 질환을 치료하는 방법을 제공할 수 있다.
Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | kor |
recordid | cdi_epo_espacenet_KR20240021943A |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | 암의 치료에 사용하기 위한 마스킹된 유형 I 인터페론 (IFNα 및 IFNβ)을 포함하는 융합 단백질 조성물 및 그의 방법 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T18%3A27%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VASUTHASAWAT%20ALEX&rft.date=2024-02-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240021943A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |